These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33050787)

  • 1. Virtual HIV pre-exposure prophylaxis outpatient service in the era of COVID-19.
    Quirke S; Quinn L; Hegarty D; Loy A; Lyons F; Mulcahy F; Devitt E
    Int J STD AIDS; 2021 Jan; 32(1):100-103. PubMed ID: 33050787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to "PrEP" for HIV Prevention in Women.
    Ntim GJ; Kransdorf LN
    J Womens Health (Larchmt); 2017 Feb; 26(2):195-196. PubMed ID: 28140756
    [No Abstract]   [Full Text] [Related]  

  • 3. Preexposure Prophylaxis with Tenofovir/Emtricitabine Prevents HIV Infection In Men who Have Unprotected Anal Intercourse.
    Ebell MH
    Am Fam Physician; 2016 Mar; 93(6):520. PubMed ID: 26977839
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantification of tenofovir disoproxil fumarate and emtricitabine in generic pre-exposure prophylaxis tablets obtained from the internet.
    Wang X; Nutland W; Brady M; Green I; Boffito M; McClure M
    Int J STD AIDS; 2019 Jul; 30(8):765-768. PubMed ID: 31072205
    [No Abstract]   [Full Text] [Related]  

  • 5. InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.
    Wang X; Nwokolo N; Korologou-Linden R; Hill A; Whitlock G; Day-Weber I; McClure MO; Boffito M
    HIV Med; 2018 Jan; 19(1):1-6. PubMed ID: 28657199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-exposure prophylaxis is effective at preventing HIV in high risk gay men, study shows.
    Mayor S
    BMJ; 2015 Sep; 351():h4860. PubMed ID: 26359448
    [No Abstract]   [Full Text] [Related]  

  • 7. Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care.
    Tung EL; Thomas A; Eichner A; Shalit P
    Sex Health; 2018 Nov; 15(6):556-561. PubMed ID: 30401342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: A comparative pre-exposure prophylaxis efficacy study against HIV-1 vaginal transmission.
    Mandal S; Kang G; Prathipati PK; Zhou Y; Fan W; Li Q; Destache CJ
    J Control Release; 2019 Jan; 294():216-225. PubMed ID: 30576746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily or on-demand oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis: experience from a hospital-based clinic in France.
    Noret M; Balavoine S; Pintado C; Siguier M; Brun A; Bauer R; Loze B; Leplatois A; Aslan A; Moudachirou K; Delaugerre C; Rozenbaum W; Molina JM
    AIDS; 2018 Sep; 32(15):2161-2169. PubMed ID: 30212403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Trigeminal Neuralgia Associated with Initiation of Emtricitabine/Tenofovir for HIV Pre-Exposure Prophylaxis.
    Van Slyke L; Scott M
    J Int Assoc Provid AIDS Care; 2018; 17():2325958218760846. PubMed ID: 29534653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of M184V mutant human immunodeficiency virus in a patient using daily pre-exposure prophylaxis.
    Jewsbury S; Ward C
    Int J STD AIDS; 2020 Jan; 31(1):85-87. PubMed ID: 31801029
    [No Abstract]   [Full Text] [Related]  

  • 12. Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges.
    Krakower DS; Mayer KH
    Drugs; 2015 Feb; 75(3):243-51. PubMed ID: 25673022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better late than never: PrEP in England.
    The Lancet Hiv
    Lancet HIV; 2017 Jan; 4(1):e1. PubMed ID: 28007341
    [No Abstract]   [Full Text] [Related]  

  • 14. Is sub-Saharan Africa ready for pre-exposure prophylaxis?
    Bernier A; Gapiya J; Sylla A; Anoma C; Somda M; Dah E; Aranda JF; Himmich H
    Lancet HIV; 2016 Apr; 3(4):e154-5. PubMed ID: 27036989
    [No Abstract]   [Full Text] [Related]  

  • 15. Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention.
    Rowan SE; Patel RR; Schneider JA; Smith DK
    Lancet HIV; 2021 Feb; 8(2):e114-e120. PubMed ID: 33128874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational Approach to Predicting the Efficacy of Maraviroc-Based Regimens as HIV Preexposure Prophylaxis.
    Srinivas N; Cottrell M; Maffuid K; Prince HA; Nelson JAE; White N; Sykes C; Dellon ES; Madanick RD; Shaheen NJ; Gonzalez D; Kashuba ADM
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31740561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation.
    Weis JF; Baeten JM; McCoy CO; Warth C; Donnell D; Thomas KK; Hendrix CW; Marzinke MA; Mugo N; Matsen FA; Celum C; Lehman DA;
    AIDS; 2016 Jan; 30(1):31-5. PubMed ID: 26731753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
    Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
    Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UK PrEP decision re-ignites HIV activism.
    The Lancet
    Lancet; 2016 Apr; 387(10027):1484. PubMed ID: 27115959
    [No Abstract]   [Full Text] [Related]  

  • 20. The averted infections ratio: a novel measure of effectiveness of experimental HIV pre-exposure prophylaxis agents.
    Dunn DT; Glidden DV; Stirrup OT; McCormack S
    Lancet HIV; 2018 Jun; 5(6):e329-e334. PubMed ID: 29893246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.